Location History:
- Seattle, WA (US) (2005)
- Cambridge, MA (US) (2004 - 2007)
Company Filing History:
4 out of 8,393 
1 out of 2,893 
Years Active: 2004-2007
Title: Rajesh Ranganathan: Innovator in Serotonin Research
Introduction
Rajesh Ranganathan is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of serotonin research. With a total of four patents to his name, Ranganathan has made strides in understanding the biological mechanisms of serotonin and its implications for various medical conditions.
Latest Patents
Ranganathan's latest patents include groundbreaking inventions such as the CeSERT genes, proteins, and modulatory compounds. This invention features substantially pure nucleic acid sequences encoding wild-type or mutant serotonin reuptake transporter (SERT) polypeptides, as well as the polypeptides themselves. The invention also outlines methods for identifying modulators of the biological activity of a SERT and for determining if such a modulator has a secondary target. Additionally, it includes methods for treating conditions in subjects. Another notable patent is the serotonin-gated anion channel, which is a novel channel that is permeable to chloride ions. This patent also discloses methods for screening therapeutics useful for treating serotonin-mediated cellular responses and conditions, along with diagnostic methods for identifying such conditions.
Career Highlights
Throughout his career, Rajesh Ranganathan has worked with esteemed institutions such as the Massachusetts Institute of Technology and The General Hospital Corporation. His work has significantly advanced the understanding of serotonin's role in various biological processes.
Collaborations
Ranganathan has collaborated with notable figures in the field, including H Robert Horvitz and Stephen C Cannon. These collaborations have further enriched his research and contributed to the development of innovative solutions in serotonin-related studies.
Conclusion
Rajesh Ranganathan's contributions to serotonin research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in understanding and treating serotonin-related conditions.